Hyp-Pit Pharmacology Flashcards

1
Q

Controversy for usage of GH in children with idiopathic short stature? (2)

A
  1. Response to GH is highly variable

2. Benefit vs huge cost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Uses of GH in adult? (4)

A
  1. Tuner’s syndrome
  2. Deficiency in adult – pituitary tumor or post-radiation/surgery
  3. Wasting or cachexia in AIDS patients
  4. Short bowel syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Adverse Reaction of GH

A
  1. Insulin resistance => glucose intolerance
  2. Increased risk idiopathic intracranial hypertension
  3. Misuse in athletes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Tesamorelin

A
  • GHRH

* use in HIV pt with lipodystrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

GHRH Pharmacokinetics

A
  1. Effective IV, SC
  2. Adverse effect rare
  3. Gs-GPCR => increase cAMP and Ca2+
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

GHRH Uses

A
  1. Diagnostic evaluation for GH deficiency

2. Potential use in GH-deficient children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Somatostatin

A
  1. Gi/o => decrease cAMP
  2. Decrease secretion gastric enzyme and acid
  3. Reduces insulin and glucagon release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Somatostatin analogs

A
  1. Octreotide
    * given SC every 6-12 hours
    * given IM every 4 wks
  2. Lanreotide - long acting
    * given SC every 4 wks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Somatostatin clearance

A
  • Kidney

* t1/2 = 3-4 min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Medical therapies for acromegaly

A
  1. Somatostatin analog
    * Lanreotide - long acting; PREFERRED!!
  2. GH receptor antagonist
    * Pegvisomant - mutated GH extend t1/2; single dose SC
  3. Dopamine agonist
    * Cabergoline - not as effective, adjuvant management
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Somatostatin non-pituitary uses

A

octreotide - control bleeding from esophageal varices and GI hemorrhage

  • direct action on vascular SM
  • Fever side effects than vasopressin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Adverse Reaction Somatostatin

A

Hyperglycemia => improve eventually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prolactin Pharmacodynamics

A
  1. Inhibitory = Dopamine D2 receptor
  2. Stimulus for release = suckling
  3. Stimulate milk production with appropriate
    * insulin
    * estrogen
    * progestin
    * corticosteroid
  4. Inhibit FSH/LH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drugs cause hyperprolactinemia

A
  1. Antipsychotic (anti-Dopamine)

2. Anti-emetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Prolactin useage

A
  1. Hypo-prolactinemia => currently NO commercially available

2. Hyper-prolactinemia => D2 agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dopamine Agonist agents

A
  1. Cabergoline!!
    * more effective = more selective for D2 receptor
    * better tolerance
  2. Bromocriptine
    * Side effects: n/v, postural hypotension
    * Also activate D1 receptor
17
Q

Desmopressin (DDAVP)

A

ADH analog = more stable, longer t1/2 (1.5-2.5hrs)

18
Q

ADH

A
  • Act on collecting tubules
  • Stimulus = !! rising blood osmolality; decrease circulating volume
  • Inhibited release = ethanol
19
Q

ADH Pharmacodynamics

A
  1. Renal action
    * V2 receptor = Gs
    * Increase water channels exocytosis => increase Water permeability => decrease water secretion
  2. Non-renal
    * release coagulation factor VIII and von Willebrand
20
Q

ADH act on V1 receptor

A

V1 receptor = Gq (increase Ca++)
=> * vasoconstriction
* Pressor response = only at much higher Cp

21
Q

Central DI treatment

A
  • 1st line = dDAVP (longer t1/2; no vasopressor effect)

* 2nd line = ADH